Cargando…

The Retinoblastoma (RB) Tumor Suppressor: Pushing Back against Genome Instability on Multiple Fronts

The retinoblastoma (RB) tumor suppressor is known as a master regulator of the cell cycle. RB is mutated or functionally inactivated in the majority of human cancers. This transcriptional regulator exerts its function in cell cycle control through its interaction with the E2F family of transcription...

Descripción completa

Detalles Bibliográficos
Autores principales: Vélez-Cruz, Renier, Johnson, David G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578165/
https://www.ncbi.nlm.nih.gov/pubmed/28812991
http://dx.doi.org/10.3390/ijms18081776
_version_ 1783260484372267008
author Vélez-Cruz, Renier
Johnson, David G.
author_facet Vélez-Cruz, Renier
Johnson, David G.
author_sort Vélez-Cruz, Renier
collection PubMed
description The retinoblastoma (RB) tumor suppressor is known as a master regulator of the cell cycle. RB is mutated or functionally inactivated in the majority of human cancers. This transcriptional regulator exerts its function in cell cycle control through its interaction with the E2F family of transcription factors and with chromatin remodelers and modifiers that contribute to the repression of genes important for cell cycle progression. Over the years, studies have shown that RB participates in multiple processes in addition to cell cycle control. Indeed, RB is known to interact with over 200 different proteins and likely exists in multiple complexes. RB, in some cases, acts through its interaction with E2F1, other members of the pocket protein family (p107 and p130), and/or chromatin remodelers and modifiers. RB is a tumor suppressor with important chromatin regulatory functions that affect genomic stability. These functions include the role of RB in DNA repair, telomere maintenance, chromosome condensation and cohesion, and silencing of repetitive regions. In this review we will discuss recent advances in RB biology related to RB, partner proteins, and their non-transcriptional functions fighting back against genomic instability.
format Online
Article
Text
id pubmed-5578165
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-55781652017-09-05 The Retinoblastoma (RB) Tumor Suppressor: Pushing Back against Genome Instability on Multiple Fronts Vélez-Cruz, Renier Johnson, David G. Int J Mol Sci Review The retinoblastoma (RB) tumor suppressor is known as a master regulator of the cell cycle. RB is mutated or functionally inactivated in the majority of human cancers. This transcriptional regulator exerts its function in cell cycle control through its interaction with the E2F family of transcription factors and with chromatin remodelers and modifiers that contribute to the repression of genes important for cell cycle progression. Over the years, studies have shown that RB participates in multiple processes in addition to cell cycle control. Indeed, RB is known to interact with over 200 different proteins and likely exists in multiple complexes. RB, in some cases, acts through its interaction with E2F1, other members of the pocket protein family (p107 and p130), and/or chromatin remodelers and modifiers. RB is a tumor suppressor with important chromatin regulatory functions that affect genomic stability. These functions include the role of RB in DNA repair, telomere maintenance, chromosome condensation and cohesion, and silencing of repetitive regions. In this review we will discuss recent advances in RB biology related to RB, partner proteins, and their non-transcriptional functions fighting back against genomic instability. MDPI 2017-08-16 /pmc/articles/PMC5578165/ /pubmed/28812991 http://dx.doi.org/10.3390/ijms18081776 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Vélez-Cruz, Renier
Johnson, David G.
The Retinoblastoma (RB) Tumor Suppressor: Pushing Back against Genome Instability on Multiple Fronts
title The Retinoblastoma (RB) Tumor Suppressor: Pushing Back against Genome Instability on Multiple Fronts
title_full The Retinoblastoma (RB) Tumor Suppressor: Pushing Back against Genome Instability on Multiple Fronts
title_fullStr The Retinoblastoma (RB) Tumor Suppressor: Pushing Back against Genome Instability on Multiple Fronts
title_full_unstemmed The Retinoblastoma (RB) Tumor Suppressor: Pushing Back against Genome Instability on Multiple Fronts
title_short The Retinoblastoma (RB) Tumor Suppressor: Pushing Back against Genome Instability on Multiple Fronts
title_sort retinoblastoma (rb) tumor suppressor: pushing back against genome instability on multiple fronts
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578165/
https://www.ncbi.nlm.nih.gov/pubmed/28812991
http://dx.doi.org/10.3390/ijms18081776
work_keys_str_mv AT velezcruzrenier theretinoblastomarbtumorsuppressorpushingbackagainstgenomeinstabilityonmultiplefronts
AT johnsondavidg theretinoblastomarbtumorsuppressorpushingbackagainstgenomeinstabilityonmultiplefronts
AT velezcruzrenier retinoblastomarbtumorsuppressorpushingbackagainstgenomeinstabilityonmultiplefronts
AT johnsondavidg retinoblastomarbtumorsuppressorpushingbackagainstgenomeinstabilityonmultiplefronts